Etodolac
Product Images NDC 21695-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 21695-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 01)

Chemical Structure (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 01)
Chemical structure diagram of Etodolac depicting its molecular composition including a benzene ring, an indole moiety with attached ethyl groups, and a carboxylic acid functional group.*
FDA Label Image

Etodolac 300mg (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 02)

Etodolac 300mg (Db60911a 2bb1 4e8c Baf0 7cf281bf5778 02)
Etodolac 300mg capsules label showing 42 capsules per package, manufactured by Novopharm Limited, Canada, and distributed by Physician Partner, a division of Rebel Distributors Corp. The label includes NDC 21695-049-42, details capsule description, lot number, expiration, and storage instructions at controlled room temperature 15°-30°C (59°-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.